FDA issues draft guidance of clinical pharmacology, labeling considerations for peptide drug products
Regulatory NewsJeff Craven
North AmericaPharmaceuticalsResearch, Design and DevelopmentRegulatory NewsJeff CravenNorth AmericaPharmaceuticalsResearch, Design and Development